Flow cytometric detection of the mitochondrial BCL‐2 protein in normal and neoplastic human lymphoid cells

Wiley - Tập 13 Số 5 - Trang 502-509 - 1992
A Aiello1, Domenico Delia2, Maria Grazia Borrello2, D Biassoni2, Roberto Giardini2, Enrico Fontanella2, Francesco Pezzella3, Karen Pulford3, Marco A. Pierotti2, Giuseppe Della Porta4
1Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
2Istituto Nazionale per to Studio e la Cura dei Tumori, Milan, Italy
3John Radcliffe Hospital Headington Oxford United Kingdom
4Istituto Nazionale Ricerca Cancer, Milan

Tóm tắt

AbstractThe bcl‐2 proto‐oncogene, rearranged and deregulated in B‐cell lymphomas bearing the t(14;18) translocation, encodes an inner mitochondrial membrane protein that blocks apoptotic cell death. We have developed a sensitive immunofluorescence assay for the single‐ and multicolor flow cytometric analysis of bcl‐2 protein in relation to other markers and cell cycle, based on a fixation‐permeation step of cells with paraformaldehyde and Triton X100 and the use of a bcl‐2 specific monoclonal antibody (MoAb). As an application of this method, we have examined the expression of bcl‐2 in normal and neoplastic lymphoid cells. We have found that > 80% of normal Tand B‐cells are bcl‐2 positive; following in vitro mitogen activation, the bcl‐2 reactivity decreased slightly in the former but markedly in latter cells. In both cases the bcl‐2 expression was not restricted to a specific phase of the cell cycle, as evidenced by two‐color analysis. On lymphoblastoid cell lines, the bcl‐2 staining intensity was variable and not necessarily correlated to molecular rearrangements of the bcl‐2 gene. Among fresh B‐cell non‐Hodgkin's lymphomas (B‐NHL), most sporadic Burkitt's cases were bcl‐2 negative. Of four centroblastic‐centrocytic cases with rearrangements of the bcl‐2 gene, only two presented elevated amounts of bcl‐2 protein, indicating that the levels of bcl‐2 are not diagnostic of the translocation. The flow cytometric analysis of bcl‐2 protein allows study and quantification, as the single cell level and in selected cell subsets, of the expression of the bcl‐2 gene and provides an important tool for assessing its role in hematopoietic cell development, proliferation, and neoplastic conversion.

Từ khóa


Tài liệu tham khảo

10.1002/hon.2900080407

Amakawa R, 1991, Genomic organization of IgH gene compared with the expression of bcl‐2 gene in t(14;18)‐positive lymphomas, Blood, 77, 1970, 10.1182/blood.V77.9.1970.1970

10.1016/S0092-8674(85)80070-2

10.1128/MCB.9.2.701

10.1016/0092-8674(86)90362-4

10.1073/pnas.82.21.7439

10.1084/jem.164.1.315

10.1002/eji.1830140809

Delia D, 1989, Clonal immunoglobulin gene rearrangements and normal T‐cell receptor bcl‐2 and c‐myc genes in primary cutaneous B‐cell lymphomas, Cancer Res, 49, 4901

Dorken B, 1989, Leucocyte Typing IV, 1532

Dyer MJS, A new human B‐cell non‐Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t(14;18) and t(4;11) chromosomal translocations, Blood, 75, 709, 10.1182/blood.V75.3.709.709

10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4

10.1016/0003-2697(83)90418-9

10.1016/0003-2697(84)90381-6

10.1172/JCI113235

10.1002/eji.1830170421

10.1038/342195a0

10.1038/348334a0

10.1073/pnas.88.16.6961

Hua C, 1990, Mechanisms of bcl‐2 activation in human follicular lymphomas, Oncogene, 5, 233

Kastan MB, 1989, Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative activity status of normal human hematopoietic cells, Blood, 74, 1517, 10.1182/blood.V74.5.1517.1517

10.1016/0092-8674(89)90174-8

10.1002/gcc.2870030206

10.1038/346189a0

10.4049/jimmunol.144.9.3602

10.1038/353071a0

Pezzella F, 1990, Expression of the bcl‐2 oncogene protein is not specific for the 14;18 chromosomal translocation, Am J Pathol, 137, 225

10.1016/0092-8674(81)90400-1

10.1126/science.3495884

10.1016/S0140-6736(88)90367-4

Tanaka S, 1992, Frequent incidence of somatic point mutations in translocated bcl‐2 oncogenes of non‐Hodgkin's Lymphomas, Blood, 79, 229, 10.1182/blood.V79.1.229.229

10.1002/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2

10.1073/pnas.83.14.5214

Tsujimoto Y., 1957, Characterization of the protein product of bcl‐2, the gene involved in follicular lymphomas, Oncogene, 2, 3

Tsujimoto Y, 1989, Stress resistance conferred by high level of bcl‐2a protein in human B lymphoblastoid cell, Oncogene, 4, 1331

10.1038/335440a0

10.1016/0092-8674(91)90002-G

10.1182/blood.V78.4.1062.1062